To hear about similar clinical trials, please enter your email below
Trial Title:
Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
NCT ID:
NCT05496972
Condition:
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Conditions: Official terms:
Neoplasms
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Behavioral
Intervention name:
Survey Administration
Description:
Patients and providers complete survey over 10 minutes about their perspectives on the
use of telemedicine
Arm group label:
Telemedicine Visits
Summary:
To understand more about the opinions of patients and health providers on the use of
telemedicine in radiation oncology.
Detailed description:
Primary Objective:
To characterize patient and provider satisfaction with telemedicine in RO
Secondary Objective:
- To provide evidence for or against the use of telemedicine in radiation oncology
(RO)
- To assess the feasibility of and value added by telemedicine in RO
- To describe barriers and facilitators to telemedicine in RO
- To identify preferred use cases for telemedicine in RO
Criteria for eligibility:
Study pop:
MD Anderson Cancer Center
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patients will be eligible if they are aged 18 or older and have undergone at least 1
telemedicine encounter (video visit) with the radiation oncology department at MD
Anderson or its affiliates within 2 months from the initiation of the study (and
prospectively as the study enrolls). This would include weekly see visits, follow-up
visits, or consultations
- English speaking
- Access to email and internet to complete the survey
- Attending physicians in the radiation oncology department who have utilized
telemedicine will be contacted to fill out surveys reflecting their experience
Exclusion Criteria:
• Protected populations such as adults unable to consent, pregnant women, prisoners, and
individuals who are not yet adults will be excluded
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
MD Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Start date:
April 21, 2021
Completion date:
July 1, 2027
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05496972
http://www.mdanderson.org